Expression Manufacturing

Executive Summary

Expression Manufacturing, the manufacturing arm of Expression Therapeutics, is a specialized CDMO focused on lentiviral vectors and genetically engineered cell therapies. Led by industry pioneer William Swaney, former head of viral vector CMO operations at Cincinnati Children’s, the team has manufactured over 100 cGMP viral vector products, cell products, and master cell banks for the NIH and various academic and commercial clients, including FDA-approved therapies. With extensive experience in scaling complex biologics, Expression Manufacturing is positioned as a key partner for gene and cell therapy developers. The company, headquartered in Alachua, Florida, has been operating since 2009 and operates as a private entity with an approved manufacturing status, suggesting established regulatory compliance and operational readiness.

Upcoming Catalysts (preview)

• Q4 2026New CDMO partnership with a major gene therapy developer60% success
• Q2 2027Expansion of manufacturing capacity or facility upgrade55% success
• Q1 2028Commercial launch of a proprietary lentiviral vector product40% success